Evaluation of the Effect of Respiratory Physiotherapy by Mechanical In-exsufflator on Respiratory Function in Patients With Amyotrophic Lateral Sclerosis: A Pilot Study
This pilot study, sponsored by the University Hospital of Toulouse, aims to evaluate the efficacy of the Mechanical In-Exsufflator (MIE) in improving respiratory function in patients with Amyotrophic Lateral Sclerosis (ALS). Given the lack of curative treatments for ALS, this study could position MIE as a supportive therapeutic device in respiratory management, potentially enhancing patient quality of life. The market for ALS management is growing, with increasing focus on supportive therapies. The results of this study may influence future reimbursement policies and market access strategies for MIE devices in Europe and beyond. Competitive implications include the need to monitor other respiratory support devices and therapies targeting ALS and similar neurodegenerative conditions.
Indication: Amyotrophic Lateral Sclerosis
Modality: medical device
Target: Mechanical In-Exsufflator (MIE) for respiratory function enhancement in ALS patients.
Sponsor: University Hospital, Toulouse
Source URL: ClinicalTrials.gov
Source updated: Detailed source ingestion pending
Ingested: Jul 02, 2026
Model: trialsignal-ai-v1
Validation: validated
Matched by target_normalized: Mechanical In-Exsufflator (MIE) for respiratory function enhancement in ALS patients.
View original source fields
Condition raw: Amyotrophic Lateral Sclerosis
Condition normalized: Amyotrophic Lateral Sclerosis
Modality raw: medical device
Modality normalized: medical device
Target raw: Mechanical In-Exsufflator (MIE) for respiratory function enhancement in ALS patients.
Target normalized: Mechanical In-Exsufflator (MIE) for respiratory function enhancement in ALS patients.